Table of Contents
Our Services
Connect With Us
Medical device registration in Saudi Arabia is the mandatory process of obtaining a Medical Device Marketing Authorization (MDMA) from the Saudi Food and Drug Authority (SFDA) before any medical device or IVD can be legally sold in the Kingdom. Since January 2022, all devices must follow the MDMA2 (Saudi Route) — requiring a complete Technical File Assessment (TFA) submitted through the SFDA’s GHAD online portal. Devices are classified into four risk classes (A, B, C, D), and an in-country Authorized Representative (AR) is mandatory for all foreign manufacturers. The MDMA certificate is valid for 3 years and must be renewed before expiry. Typical approval timelines range from 2 to 14 months depending on device class and documentation quality.
Why Saudi Arabia? The $25 Billion Healthcare Opportunity
If you are a medical device manufacturer looking to expand in the Middle East, Saudi Arabia should be at the top of your list. Saudi Arabia’s healthcare sector is valued at over USD 25 billion and continues to grow at a rapid pace. The country’s Vision 2030 programme is pumping billions into new hospitals, diagnostic centres, and specialist care facilities — and every single one of them needs medical devices.
The medical device market in Saudi Arabia is projected to grow from $2.0 billion in 2022 to $3.3 billion by 2032 at a compound annual growth rate of 5.9%. That growth is driven by three powerful forces: a young, growing population that is ageing rapidly, rising public awareness of health and chronic disease management, and the government’s ambitious commitment to making quality healthcare accessible across the Kingdom.
Here is what makes Saudi Arabia uniquely attractive for device manufacturers in 2026:
- Gateway to the GCC: SFDA registration is widely recognised across the Gulf Cooperation Council — UAE, Kuwait, Bahrain, Oman, and Qatar — making it a single entry point into a massive regional market.
- Government hospital tenders require SFDA approval: Without a valid MDMA certificate, you simply cannot supply public hospitals or participate in any government procurement.
- CE-aligned regulations reduce duplication: SFDA’s technical framework closely mirrors EU MDR — so if you already have European CE Marking documentation, a significant portion of your technical file is already done.
- 3-year MDMA validity: Once approved, your certificate gives you a stable 3-year market window to build distribution and grow revenue before renewal.
- Underserved segments: Orthopaedics, diagnostics, cardiology, and home healthcare are growing segments where international manufacturers are actively needed.
💡 TRACCGLOBAL INSIGHT
Many manufacturers hesitate because they think SFDA is complicated. It is not complicated — it is structured. With the right regulatory partner, medical device registration in Saudi Arabia becomes a clear, predictable process with defined steps and timelines. That is exactly what Traccglobal delivers.
What is SFDA? Understanding Saudi Arabia's Medical Device Regulator
The SFDA full form is Saudi Food and Drug Authority. It is the Kingdom of Saudi Arabia’s national regulatory body responsible for overseeing the safety, quality, and performance of food, drugs, medical devices, and in vitro diagnostics (IVDs). The SFDA operates under the Council of Ministers and carries three core mandates: legislative, executive, and market surveillance.
The SFDA regulates medical devices through its Medical Devices Sector (MDS). It is a member of the International Medical Device Regulators Forum (IMDRF), which means its standards are aligned with global best practices including EU MDR, US FDA, and the Global Harmonization Task Force (GHTF) principles.
Saudi Arabia’s medical device regulations are primarily governed by the Medical Devices and Supplies Regulation, which came into full effect in 2021. This law draws heavily from EU MDR 2017/745, making it familiar territory for manufacturers who already hold CE Marking.
The SFDA requires that all medical devices and IVDs obtain a Medical Device Marketing Authorization (MDMA) certificate before they can be imported, sold, distributed, or marketed in Saudi Arabia. There are no exceptions for foreign manufacturers — and non-compliance carries serious consequences including product seizure, fines, and import bans.
⚠️ 2022 REGULATION UPDATE — CRITICAL TO KNOW
From January 2022, the old GHTF route (which previously accepted CE or US FDA approvals directly) was permanently discontinued. Additionally, from September 2022, the Medical Device National Registry (MDNR) listing route for low-risk devices was also cancelled. As of 2026, ALL medical devices must follow the MDMA2 (Saudi Route) — requiring a full Technical File Assessment (TFA) through the GHAD portal, regardless of device class.
SFDA Device Classification: Class A, B, C & D Explained
Getting your SFDA device classification right is the single most important first step. Wrong classification means wrong fees, wrong documentation, and near-certain rejection. The SFDA classifies all medical devices into four risk-based classes using 22 classification rules for medical devices and 7 classification rules for IVDs — directly mirroring the EU MDR framework.
Classification depends on four key factors: the manufacturer’s intended use, the level of risk to patients and users, the degree of invasiveness in the human body, and the duration of use. Importantly, identical devices can be classified differently if used in different parts of the body — so the intended use declared in your IFU, labels, and technical file is critical.
IVD devices — diagnostic kits, reagents, test systems — follow a separate 7-rule classification system mirroring EU IVDR. IVD classification is often more complex than standard medical device classification because risk is assessed against both patient harm potential and public health impact.
✅ PRO TIP: CE CLASS TRANSFERS DIRECTLY
If your device already has an EU CE Marking classification, you can generally apply the same class directly to SFDA's system since the 22 classification rules are identical. However, you must still formally confirm the classification within your MDMA2 application — do not assume it transfers automatically without documentation.
MDMA2 Route: The Only Valid Registration Path in 2026
As of 2026, there is exactly one valid pathway for medical device registration in Saudi Arabia: the MDMA2 Saudi Route. Understanding what changed — and why — is essential before you begin building your regulatory strategy.
What Was Changed and When
Before 2022, the SFDA offered two main routes. The GHTF Route (MDMA1) allowed manufacturers with approvals from reference countries — EU, USA, Canada, Australia, and Japan — to leverage those approvals for faster Saudi registration without needing a complete technical file. This made registration significantly easier and cheaper for CE-marked or FDA-cleared devices. That route was cancelled at the end of 2021.
Separately, low-risk Class A devices (non-sterile, non-measuring, non-novel) could previously be registered via the Medical Device National Registry (MDNR) — a simplified listing process without an Authorized Representative requirement. That too was cancelled in September 2022.
Today, the MDMA2 Saudi Route is the only option. Key characteristics:
- Applicable to ALL device classes including Class A — no device is exempt
- Requires a complete Technical File Assessment (TFA) submitted through the GHAD portal
- ISO 13485:2016 QMS certificate is mandatory for all classes, including Class A
- CE Marking or US FDA clearance is not required but significantly helps support clinical data
- Up to 50 devices can be bundled in a single MDMA application (same class, same manufacturer, same intended use)
- MDMA certificate is valid for 3 years
- An Authorized Representative (AR) in Saudi Arabia is mandatory for all foreign manufacturers
🔄 ALREADY HAVE CE OR CDSCO REGISTRATION?
If your device already holds CE Marking or CDSCO registration in India, your existing clinical evaluation, post-market data, and QMS documentation serve as a strong foundation for the SFDA TFA. Traccglobal specialises in converting and adapting CE and CDSCO documentation to SFDA standards — significantly reducing cost and build time for your Saudi TFA.
Step-by-Step SFDA Medical Device Registration Process (2026)
Here is the complete process for medical device registration in Saudi Arabia — exactly as the SFDA expects it, with practical guidance for each stage.
Step 1- Device Classification & Regulatory Strategy
Before anything else, confirm your device’s correct SFDA classification (Class A to D, or IVD class). Assess your existing regulatory approvals and design a strategy that minimises cost and timeline. Incorrect classification at this stage wastes money — it means wrong fees, wrong documentation structure, and potential rejection.
Step 2- Appoint a Licensed Authorized Representative (AR) in Saudi Arabia
All foreign manufacturers must appoint a licensed AR in the Kingdom before submitting any application. The AR must hold an annual-renewable AR License from the SFDA, have a current GHAD portal account, and be legally responsible for all regulatory communications and post-market obligations. A manufacturer can have only one AR per device class or general group — choose carefully. The AR also holds the MDMA certificate in the system, so selecting an independent AR (rather than your distributor) gives you full control over registration ownership.
Step 3- Obtain Establishment License (MDEL) from SFDA
Before submitting your product MDMA application, the manufacturer or its AR must obtain an Establishment License from the SFDA. This license is applied for electronically via the GHAD system and is valid for five years. Both manufacturers and importers/distributors operating in Saudi Arabia require this license. Without it, no product application can proceed.
Step 4- Prepare the Technical File Assessment (TFA)
This is the most critical and time-intensive step. The SFDA TFA closely mirrors EU MDR Annex II technical documentation. It includes the device description and specifications, design and manufacturing information, labeling and IFU in both English and Arabic, ISO 13485:2016 certificate with last audit report, Clinical Evaluation Report (CER), Risk Management File (ISO 14971), biocompatibility testing (ISO 10993), electrical safety and EMC validation, sterilisation and shelf-life validation (if applicable), Post-Market Surveillance plan, and Unique Device Identifier (UDI) information. Higher-risk Class C and D devices additionally need annual PSURs, a Summary of Safety and Clinical Performance (SSCP), and potentially Post-Market Clinical Follow-up (PMCF) evidence.
Step 5- Submit Application Through the GHAD Portal
The SFDA uses the GHAD e-portal for all MDMA submissions. Your AR submits the complete application, all technical documentation, and supporting forms through GHAD. The system conducts an initial completeness check — any missing document at this stage means the application is returned without entering formal review. Ensuring zero-error submission at this stage is critical to timeline management.
Step 6- Pay SFDA Assessment Fees
After the completeness check is passed, assessment fees are paid through the GHAD portal. SFDA registration fees in Saudi Arabia vary by device class — starting from 500 SAR for low-risk Class A devices. Higher-class devices carry proportionally higher fees. Fee payment triggers the formal regulatory review clock.
Step 7- Respond to SFDA Queries (AIRs) Within 10 Days
The official SFDA review period is 35 working days. During review, the SFDA may raise Additional Information Requests (AIRs) seeking clarification, supplementary data, or additional documents. The SFDA expects prompt responses — ideally within 10 days. Slow responses are the single most common cause of timeline extension. For Class C and D devices, the SFDA may also request product samples for testing or schedule an on-site manufacturing facility audit.
Step 8- Receive MDMA Certificate — Enter the Saudi Market
Once the SFDA is satisfied with the documentation, it issues the MDMA certificate in both Arabic and English. The certificate includes the manufacturer’s details, device identification, National Listing Numbers, certificate number, and validity period (3 years). You are now legally authorised to market and sell your medical device across Saudi Arabia. Post-market obligations begin immediately — PSUR submissions, adverse event reporting to the NCMDR, and UDI compliance must be maintained throughout the certificate period.
Key Documents Required for SFDA Medical Device Registration
A complete and accurate Technical File is the single most important factor in getting fast SFDA approval. Here is a class-by-class breakdown of what the Saudi Food and Drug Authority requires in 2026:
A Note on Saudi-DI (UDI) Compliance
Saudi Arabia has its own Unique Device Identification system called Saudi-DI, which follows international UDI standards. All non-exempted medical devices sold in Saudi Arabia must comply with Saudi-DI requirements. Manufacturers and their Authorized Representatives are directly responsible for providing and maintaining accurate UDI data in the SFDA system. UDI compliance is mandatory — it cannot be deferred after MDMA approval.
Arabic Labeling Requirements
Labeling requirements are a common source of SFDA queries. Professional-use medical devices must have labeling and instructions for use (IFU) provided in English as a minimum. Home-use medical devices must have labeling in Arabic. All technical documentation must be submitted in English. Many manufacturers underestimate the time and cost of professional Arabic translation — factor this into your timeline early.
Timelines & Fees: What to Realistically Expect in 2026
The official SFDA review period is 35 working days. However, actual timelines are almost always longer because of query rounds (AIRs), completeness checks, fee processing, and for Class C/D devices, potential site audit scheduling. The realistic total timeline from submitting your first document to receiving your MDMA certificate ranges from 2 months for straightforward Class A devices to 14 months or more for Class D implantables with complex clinical evidence requirements.
Timeline factors that most commonly cause delays include incomplete clinical evaluation reports, incorrect or mismatched device classification, slow query responses from the manufacturer’s side, Arabic labeling issues, and ISO 13485 certificates that have expired or are issued by an unrecognised certification body. Getting these right in your initial submission is the most effective timeline optimisation strategy available.
Real Case Studies: How Manufacturers Got SFDA Approval
These are real regulatory challenges that manufacturers faced when pursuing medical device registration in Saudi Arabia. These case studies reflect the kind of complex, practical situations that Traccglobal handles for its clients. Identifying details are kept confidential.
German Orthopaedic Device Manufacturer
Class D — Spinal Implant Systems | MDMA2 Route
A German manufacturer of spinal implant systems spent six months attempting to self-manage their SFDA Technical File Assessment. Their clinical evaluation was structured for EU MDR Annex XIV, which did not meet SFDA requirements. The submission had multiple queries and risk of rejection.
Traccglobal restructured the clinical evaluation, aligned documentation with SFDA standards, updated risk management files, localized IFU, and resolved all queries efficiently.
South Korean IVD Diagnostics Manufacturer
Class C — Immunoassay Analysers | IVD Registration
A diagnostics company faced rejection due to incorrect IVD classification and incomplete performance evaluation, requiring full rework of documentation.
Traccglobal corrected classification, rebuilt evaluation data, and submitted a complete GHAD file aligned with SFDA requirements.
Indian Medical Device Startup — First International Registration
Class B — Wound Care Products | CDSCO to SFDA
A startup with no international regulatory experience aimed to enter Saudi Arabia within a tight deadline but lacked local representation and SFDA knowledge.
Traccglobal onboarded a Saudi AR, prepared complete documentation, handled GHAD submissions, and proactively managed queries.
5 Costly Mistakes That Delay SFDA Medical Device Registration
After supporting hundreds of manufacturers with SFDA medical device registration, the same avoidable errors appear repeatedly. Here are the five most expensive mistakes — and how to avoid each one.
Wrong Device Classification
Applying under the wrong class leads to incorrect fees, improper documentation structure, and rejection. SFDA classification rules require careful validation — assumptions based on CE classification alone can result in compliance failure.
Incomplete Clinical Evaluation
Clinical evidence must align with SFDA MDS-REQ-001 standards. Missing Saudi-specific data or improper CER structure leads to immediate queries and delays in approval timelines.
Invalid or Expired AR License
An invalid Authorized Representative license can invalidate the entire application. Always verify AR compliance status before initiating the SFDA submission process.
Slow Response to SFDA Queries
Delayed responses to SFDA queries can lead to extended timelines or rejection. Timely and structured responses demonstrate regulatory readiness and improve approval chances.
Arabic Labeling Not Prepared
Arabic labeling is mandatory for Saudi Arabia. Delays in translation and approval can significantly impact product launch timelines if not planned early.
No UDI / Saudi-DI Compliance Plan
UDI compliance is mandatory for most devices. Lack of a structured Saudi-DI implementation plan can create compliance gaps post-approval.
Post-Market Obligations After MDMA Approval
Receiving your MDMA certificate is not the end of the journey — it is the beginning of your post-market regulatory obligations. The SFDA enforces these requirements seriously, and non-compliance can result in certificate suspension or market withdrawal.
Here are the ongoing obligations that every SFDA-registered manufacturer must meet:
- PSUR Submissions: Periodic Safety Update Reports must be submitted annually for Class C and D devices, and every 2 years for Class B. Class A devices require a Post-Market Surveillance Report.
- Adverse Event Reporting to NCMDR: All adverse events, field safety corrective actions, and significant safety-related complaints must be reported to the National Centre for Medical Devices Registration (NCMDR) through the SFDA system.
- Significant Change Notifications: The SFDA must be informed within 10 days of any significant change to the device or its documentation, and within 30 days for non-significant changes.
- MDMA Certificate Renewal: Your 3-year MDMA certificate must be renewed before it expires. A renewal application can be submitted 90 days before the expiry date. Allowing a certificate to lapse means your product loses legal market authorisation.
- Saudi-DI UDI Maintenance: UDI data for all devices must be kept current and accurate in the SFDA system at all times. Changes to device versions or models require UDI updates.
- Ongoing QMS Compliance: Your ISO 13485 QMS must remain certified and current throughout the MDMA certificate period. A lapsed ISO certificate puts your SFDA registration at risk.
Frequently Asked Questions About Medical Device Registration in Saudi Arabia
What is SFDA full form and what does it regulate?
How long does medical device registration in Saudi Arabia take?
Is CE Marking required for SFDA registration?
Do I need an Authorized Representative in Saudi Arabia?
What is the GHAD portal and how does SFDA submission work?
How much does SFDA medical device registration cost in Saudi Arabia?
Can I bundle multiple devices in a single MDMA application?
What happens after my SFDA certificate expires?
Does SFDA registration help with other GCC markets?
Start Your SFDA Registration with Traccglobal Today
Traccglobal provides end-to-end SFDA registration support — device classification, AR services, full TFA preparation, GHAD portal submission, 48-hour query resolution, and post-market compliance.
98% first-attempt approval. Zero-error documentation. One team, one point of contact.
Book Your Free Consultation →Speak with a senior SFDA regulatory expert. Free. No commitment.
